Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 61 for (lung OR pulmonary) AND surgery

Edit search filters
  1. Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

    Rochester, MN

  2. A Trial to Evaluate the Safety of GEN1046 in Patients with Malignant Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  3. A Study to Evaluate the Effectiveness and Safety of Rivaroxaban as Prophylaxis Treatment for Venous Thromboembolism (VTE) in Ambulatory Cancer Patients

    Rochester, MN

  4. Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)

    Rochester, MN

  5. Mechanical Ventilation Guided By Transpulmonary and Airway Driving Pressures

    Rochester, MN

  6. A Study to Collect Medical Data and Tissue from Patients with Lung Conditions Resulting in Lung Surgery.

    Rochester, MN

  7. Identification of a Plasma Proteomic Signature for Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study to Analyze Isolation, Activation and Expansion of Mutation Reactive T-cells

    Rochester, MN

  9. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now

    Rochester, MN

  10. A Study to Collect Medical and Personal Histories, Blood and/or Tumor Tissue Samples from Patients Who are Long-term Survivors of Lung Cancer

    Rochester, MN

.

Mayo Clinic Footer